Author:
Maldonado Rafael González
Reference59 articles.
1. Katzenschlager R et al. Mucuna pruriens in Parkinson's disease: A double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery, and Psychiatry. 2004;75:1677
2. Manyam BV, Dhanasekaran M, Hare TA. Effect of antiparkinson drug HP-200 (mucuna pruriens) on the central monoaminergic neurotransmitters. Phytotherapy Research. 2004;18:97-101
3. Der Giessen RV, Olanow W, Lees A, Wagner H. Method for preparing Mucuna pruriens see extract. United States Patent, US 7,470,441 B2, Dec. 30, 2008
4. Randhir R, Kwon YI, Shetty K. Improved health-relevant functionality in dark germinated mucuna pruriens sprouts by elicitation with peptide and phytochemical elicitors. Bioresource Technology. 2009;100:4507-4514
5. Raghavendra S et al. Enhanced production of L-DOPA in cell cultures of mucuna pruriens L. and mucuna prurita H. Natural Product Research. 2012;26:792-801
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献